Login / Signup

The potential role of clarithromycin addition to lenalidomide and dexamethasone therapy (BiRd) in multiple myeloma.

Takahiro KobayashiMasatomo MiuraMaiko AbumiyaTakenori NiiokaShuichi KannoNaoto Takahashi
Published in: Annals of hematology (2018)
Keyphrases
  • multiple myeloma
  • helicobacter pylori
  • low dose
  • high dose
  • helicobacter pylori infection
  • stem cells
  • newly diagnosed
  • mesenchymal stem cells
  • cell therapy
  • chronic lymphocytic leukemia